Latest News about HZNP
Recent news which mentions HZNP
Stifel Nicolaus reduced Horizon Therapeutics (HZNP) PT to $138. HZNP is trading at $66.96
August 03, 2022
Tickers
HZNP
From Best Stocks
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 03, 2022
From Benzinga
Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session
August 03, 2022
From Benzinga
Dow Jumps 350 Points; Crude Oil Drops Over 2%
August 03, 2022
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 03, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Horizon Therapeutics Begins Patient Enrolment in Phase 2 trial of Daxdilimab (HZN-7734) for Alopecia Areata
May 17, 2022
Tickers
HZNP
From Benzinga
From Benzinga
Horizon Therapeutics' Inebilizumab Scores European Approval For Spinal Cord Inflammation
May 02, 2022
Tickers
HZNP
From Benzinga
From Benzinga
Eton Pharmaceuticals Names James Gruber Finance Chief
April 11, 2022
From Benzinga
Executives Sell More Than $262M Of 5 Stocks
April 04, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.